GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer. - Wikidata - wikimedia - TriplyDB

GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer.

GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer.

http://www.wikidata.org/entity/Q36526815

about

Function of G-Protein-Coupled Estrogen Receptor-1 in Reproductive System Tumors Transactivation of Epidermal Growth Factor Receptor by G Protein-Coupled Receptors: Recent Progress, Challenges and Future Research Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer.Estrogen and androgen receptor expression in surface epithelium and inclusion cyst in the ovary of premenopausal and postmenopausal women GPER-targeted, 99mTc-labeled, nonsteroidal ligands demonstrate selective tumor imaging and in vivo estrogen binding.The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients.The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer.Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers.The status of epidermal growth factor receptor in borderline ovarian tumours.EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review Cytoplasmic GPER translocation in cancer-associated fibroblasts mediates cAMP/PKA/CREB/glycolytic axis to confer tumor cells with multidrug resistance.The P2RY2 Receptor Induces Carcinoma Cell Migration and EMT Through Cross-Talk With Epidermal Growth Factor Receptor.GPER functions as a tumor suppressor in triple-negative breast cancer cells.GPER-1 acts as a tumor suppressor in ovarian cancer.Correlation between estrogen receptor expression and prognosis in epithelial ovarian cancer: a meta-analysis.Nuclear G protein-coupled oestrogen receptor (GPR30) predicts poor survival in patients with ovarian cancer.Lack of G protein-coupled estrogen receptor (GPER) in the plasma membrane is associated with excellent long-term prognosis in breast cancer.A novel nanobody-based target module for retargeting of T lymphocytes to EGFR-expressing cancer cells via the modular UniCAR platform.

P2860

Q26744530-CBE83CB6-6CEA-4727-9760-F651B5A2913B Q26771727-06C36297-784C-420A-9E2E-2DC9D058E814 Q34022694-F33A4A4E-AFC1-4C7D-A306-DFF25BEC5817 Q34249388-FAF9625E-5E83-48B1-8D02-16916E0B033B Q34518285-1FEE2A83-00F4-489D-B03F-6824055A2E76 Q34950615-814AC043-B130-4315-85B1-9D8ABB3BA719 Q36820568-E9B7EF48-1CAF-4347-9884-565F071F17C8 Q36946741-9AE68A1E-ED39-4F42-A2FC-CB8FCCF84C4B Q36963030-05C21AD8-23EA-4C53-A766-A3A66EEA82A1 Q38652339-634262AC-2ACC-4283-B7FC-B67FE2149300 Q38741833-E9830BB9-4F9C-4DBC-BA5E-C6818F75EA1B Q38829837-D6D3C145-90C4-458D-B665-267A2F17F4EA Q39022382-02535A63-92D1-439F-8163-E5BDCACFAD39 Q41889998-C841DDAF-5129-47C0-97F3-2ECDECCAF829 Q42365343-F42EA253-011C-4111-AE1F-AF0DC38D5441 Q47221063-D51BD03C-2D7C-4006-9016-2C6BEB44A718 Q53058836-6363BAD3-6D86-48C1-99EF-EA6B547D11B9 Q54945917-99F8677A-BA47-4BED-8B8E-C33245635329

P2860

GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer.

http://www.wikidata.org/entity/Q36526815

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

GPR30 regulates the EGFR-Akt c ...... patients with ovarian cancer.

@ast

GPR30 regulates the EGFR-Akt c ...... patients with ovarian cancer.

@en

type

label

GPR30 regulates the EGFR-Akt c ...... patients with ovarian cancer.

@ast

GPR30 regulates the EGFR-Akt c ...... patients with ovarian cancer.

@en

prefLabel

GPR30 regulates the EGFR-Akt c ...... patients with ovarian cancer.

@ast

GPR30 regulates the EGFR-Akt c ...... patients with ovarian cancer.

@en

P1433

Q36526815-0D4187B3-FBF2-4AD1-A297-01527E696898

P1476

Q36526815-AC48BECB-0BA4-4414-B781-7BC53AE10BA5

P2093

Q36526815-30F80D86-91AF-4BBD-A021-B3001C6054B6

Q36526815-32491FE0-7D56-4399-AED7-FF0ACEB6C03B

Q36526815-3CA8CCA5-4928-4839-BC67-B46724F4156B

Q36526815-462B39D2-92EC-47E8-91C4-DDE8807B3AA3

Q36526815-534AACD1-3FEB-47FD-8386-C2559473A160

Q36526815-89793344-195C-451A-B022-DC43448B808C

Q36526815-914220D9-B772-4CE5-B9B5-4B06E2ECB1C4

Q36526815-93917993-D9D3-4FB4-920E-979B9CDF82F4

Q36526815-A7883FA3-083E-4B08-86B3-D70918241405

Q36526815-B3E4BFEE-959A-4A05-A77B-1E3AC03734A1

P2860

Q36526815-007DDECC-6AC7-42E2-B616-500FECF47172

Q36526815-03992986-2116-46CC-AFB4-735986A360D2

Q36526815-0C7465ED-E858-46D5-8D6F-D488056D29E3

Q36526815-0F3313F7-838E-4ADC-B5C4-240686A5B127

Q36526815-12D6B94F-4508-4156-ABDF-DF09983E8578

Q36526815-24D1D9B4-8CEB-4734-9D75-9ECCB9FEEB0B

Q36526815-2A63CCE2-8C97-4968-A8C8-A8327466E3FB

Q36526815-2DE36927-5255-47CC-8BFD-FE200B4F919B

Q36526815-2ED2929A-8FF1-41BB-BA27-AA3313C7864E

Q36526815-2F93D4EA-2334-4323-BD4D-A1D2A91AC5C0

P2888

Q36526815-4E9CF453-72FF-4FE5-BA23-2E8E8AF87363

P304

Q36526815-F2C8A46B-A3E9-4E6C-8FDF-DBBBB9DB0892

P31

Q36526815-254BBE91-F261-4598-93F8-F9AA80978E96

P356

Q36526815-B9FC0287-4F91-4048-824D-07B03A740AAC

P433

Q36526815-743D06C8-9E15-47BB-95C8-9C5372500C0A

P478

Q36526815-0BC417DE-946C-4B98-B922-144EBFFDE508

P577

Q36526815-E5477EB4-BD61-4B49-A14C-36CD21DF0A13

P5875

Q36526815-C8B7A2E5-6DAD-464D-A19D-836CC211AC7A

P6179

Q36526815-A49F4026-97C4-4845-A028-53A283236FE4

P698

Q36526815-25346FCF-5F98-4F96-BA42-521F65B49F5D

P921

Q36526815-5038F414-7518-406B-AE1A-08F9CE0389D7

P932

Q36526815-4C9565BD-07A0-45F3-9B58-34D4ECA4F909

P356

P1433

Journal of Ovarian Research

P1476

GPR30 regulates the EGFR-Akt c ...... patients with ovarian cancer.

@en

P2093

Akiko Tanabe

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kawaguchi

http://www.w3.org/2001/XMLSchema#string

Hiroshi Sasaki

http://www.w3.org/2001/XMLSchema#string

Masaaki Takai

http://www.w3.org/2001/XMLSchema#string

Masahide Ohmichi

http://www.w3.org/2001/XMLSchema#string

Masanori Kanemura

http://www.w3.org/2001/XMLSchema#string

Saha Yoo

http://www.w3.org/2001/XMLSchema#string

Satoe Fujiwara

http://www.w3.org/2001/XMLSchema#string

Satoshi Tsunetoh

http://www.w3.org/2001/XMLSchema#string

Tomohito Tanaka

http://www.w3.org/2001/XMLSchema#string

P2860

Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells

The G-protein-coupled estrogen receptor GPER in health and disease

Cancer statistics, 2010

Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues

G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF

Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma.

GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer.

GPR30 predicts poor survival for ovarian cancer

P2888

P304

35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1757-2215-5-35

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233722960

http://www.w3.org/2001/XMLSchema#string

P6179

1012382509

http://www.w3.org/2001/XMLSchema#string

P698

23163984

http://www.w3.org/2001/XMLSchema#string

P921

P932

3543193

http://www.w3.org/2001/XMLSchema#string